Skip to content

Clinical trial for the safety and effectiveness of bone cement in filling and stabilizing vertebral body

Clinical trial for the safety and effectiveness of bone cement in filling and stabilizing vertebral body

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000030563
Enrollment
Unknown
Registered
2020-03-07
Start date
2020-03-02
Completion date
Unknown
Last updated
2020-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Suitable for filling and stabilization of vertebral body

Interventions

control group:Using bone cement and injection tool mendec spine resin and kit produced by Tecres S.P.A

Sponsors

Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) The subject or guardian is willing and able to sign the informed consent; 2) The age is 18-80 years (inclusive), and the gender is not limited; 3) Patients with indications of cemented vertebral filling operation; 4) Good compliance, willing and able to follow up as required.

Exclusion criteria

Exclusion criteria: 1) The posterior edge of vertebral body has extensive bone destruction, a large range of incomplete, and definite symptoms and signs of nerve injury; 2) Active infection was found in vertebrae or other parts of the body; 3) Vertebral compression fracture with a course of more than 12 months; 4) To treat the previous operation history of bone cement filling in vertebral body adjacent to vertebral body; 5) The number of vertebrae that need to be filled with bone cement at the same time = 3; 6) The degree of vertebral compression was more than 75%, and no puncture approach was expected; 7) Allergic to the components of bone cement; 8) Severe cardiopulmonary insufficiency or other chronic diseases can not tolerate surgery; 9) Patients with coagulation dysfunction and bleeding tendency; 10) Pregnant or lactating women; 11) Mentally incapacitated or unable to understand the requirements of participating in the study; 12) Patients who participated in other clinical studies within 1 month before the start of this study; 13) The researchers believe that subjects can not follow-up, which affects the scientific integrity of the study.

Design outcomes

Primary

MeasureTime frame
The effective rate of VAS pain relief 3 days ± 1 day after operation;

Secondary

MeasureTime frame
Oswestry disability index score (ODI score);Recovery rate of vertebral height;Correction rate of Cobb angle in kyphosis;

Countries

China

Contacts

Public ContactChangqing Zhang

Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai

zhangcq@sjtu.edu.cn+86 18930177335

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026